Merck may be liable to Vioxx patients

October 1, 2004

Medical malpractice attorneys have suggested Vioxx patients may have grounds for a lawsuit. Vioxx was pulled from the market on September 30, 2004 after a study found the use of the drug doubled the risk of heart attacks and strokes. On the grounds that insufficient testing on its safety was performed, some attorneys say a lawsuit would depend on what the defendant knew, should have known or if the company withheld critical information.

Due to the widespread use of Vioxx, the potential number of patients adversely affected because of the use of the drug remains high. Many patients believe drugs approved by the FDA must be safe, but in the case of a manufacturer failing to disclose complete data or later clinical trials showing adverse effects, patients should not assume federal approval guarantees their safety.

For more information on the Vioxx recall, please contact us and learn your legal rights and options.
The information contained in this website is for informational purposes only and is not intended to be legal advice. The attorney-client relationship can only be formed by written agreement of the parties. All trademarks are the property of their owners. Sanford Stevenson Riff LLP are not affiliated with the manufacturers of Vioxx or Bextra, nor is this website affiliated, sponsored, or endorsed by Merck or Pfizer. The attorneys of Sanford Stevenson Riff LLP are licensed to practice law only in the State of Texas. Other lawyers likely to be associated with the handling of these claims.